Perspectum Lands Top Spot in Alantra Pharma Fast 50 Rankings. Read more
Non-invasive quantification of liver health in NASH (N-QUAN): A prospective diagnostic accuracy study
 |
Summary A multi-centre, prospective, cross-sectional, observational study to evaluate in patients with suspected NASH referred for liver biopsy, the diagnostic performance of cT1 at discriminating those with NAS ≥4 & F≥2 from those without. Goal is to enroll 225 patients across 4 sites in the US. |
 |
Disease Area Liver Disease |
 |
Product LiverMultiScan |
 |
Status Approved by Ethics Committee |
 |
Country USA |
 |
Website |